🇺🇸 FDA
Patent

US 12326492

Systems and methods of detecting interstitial cystitis

granted A61KA61K49/0004A61K49/103

Quick answer

US patent 12326492 (Systems and methods of detecting interstitial cystitis) held by LIPELLA PHARMACEUTICALS, INC. expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LIPELLA PHARMACEUTICALS, INC.
Grant date
Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K49/0004, A61K49/103, A61K49/105, A61K49/1827